Effects of active treatment discontinuation in patients with a CD4(+) T-cell nadir greater than 350 cells/mm(3)

Authored by: Pogany Katalin, Vanvalkengoed Irene G., Prins Jan M., Nieuwkerk Pythia T., van der Ende Ineke, Kauffman Robbert H., Kroon Frank P., Verbon Annelies, Nievaard Marianne F., Lange Joep M. A., Brinkman Kees
In: JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 44(4), 2007, p.395-400
http://www.ncbi.nlm.nih.gov/pubmed/17195761